Claim being checked · Version 1 · Reviewed
“P21 improves memory or treats Alzheimer’s disease in people.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Not established. The reviewed evidence does not establish this statement. This does not prove it can never be true.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for P21 peptide.
01 · Answer
Not established
The reviewed studies used mice, rats, or cells. The P021 registry search found no study in people. Animal or cell findings cannot show that P21 treats people.
- What kind of evidence this is
- No reliable human outcome evidence. No reliable study in people shows the health outcome in this statement.
- What this answer covers
- Memory or Alzheimer’s disease outcomes in people who received a verified P21 study product. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Clinical outcomes. What a study measured about people's health, symptoms, or ability to function.
02 · Sources
Read the sources behind this answer
01P21 learning, memory, and nerve-cell study in normal micePubMed · FEBS Letters · Preclinical · 2010
Defines the evidence limit02P021 tau study in aged ratsPubMed · Journal of Alzheimer’s Disease · Preclinical · 2015
Defines the evidence limit03Early P021 study in an Alzheimer-like mouse modelPubMed · Alzheimer’s Research & Therapy · Preclinical · 2017
Defines the evidence limit04P021 study in lab-grown human nerve cells and a mouse modelPubMed · Journal of Neurodevelopmental Disorders · Preclinical · 2024
Defines the evidence limit05ClinicalTrials.gov intervention search for P021ClinicalTrials.gov · Trial registry · 2026
Defines the evidence limit
Defines the evidence limit02P021 tau study in aged ratsPubMed · Journal of Alzheimer’s Disease · Preclinical · 2015
Defines the evidence limit03Early P021 study in an Alzheimer-like mouse modelPubMed · Alzheimer’s Research & Therapy · Preclinical · 2017
Defines the evidence limit04P021 study in lab-grown human nerve cells and a mouse modelPubMed · Journal of Neurodevelopmental Disorders · Preclinical · 2024
Defines the evidence limit05ClinicalTrials.gov intervention search for P021ClinicalTrials.gov · Trial registry · 2026
Defines the evidence limit
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.